Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped

T. Rispens, A. Vennegoor, G.J. Wolbink, C.H. Polman, J. Killestein

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)899-901
JournalMultiple Sclerosis
Volume18
Issue number6
DOIs
Publication statusPublished - 2012

Cite this